Central nervous system antiretroviral efficacy in HIV infection: a qualitative and quantitative review and implications for future research
Open Access
- 22 November 2011
- journal article
- review article
- Published by Springer Nature in BMC Neurology
- Vol. 11 (1) , 148
Abstract
There is conflicting information as to whether antiretroviral drugs with better central nervous system (CNS) penetration (neuroHAART) assist in improving neurocognitive function and suppressing cerebrospinal fluid (CSF) HIV RNA. The current review aims to better synthesise existing literature by using an innovative two-phase review approach (qualitative and quantitative) to overcome methodological differences between studies.Keywords
This publication has 38 references indexed in Scilit:
- Antiretroviral therapy CNS penetration and HIV-1–associated CNS diseaseNeurology, 2011
- Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohortAIDS, 2011
- Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive personsNeurology, 2010
- Statistical power analyses using G*Power 3.1: Tests for correlation and regression analysesBehavior Research Methods, 2009
- Impact of HAART and CNS-penetrating antiretroviral regimens on HIV encephalopathy among perinatally infected children and adolescentsAIDS, 2009
- Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapyNeurology, 2009
- Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performanceAIDS, 2009
- Validation of the CNS Penetration-Effectiveness Rank for Quantifying Antiretroviral Penetration Into the Central Nervous SystemArchives of Neurology, 2008
- Updated research nosology for HIV-associated neurocognitive disordersNeurology, 2007
- Genetic Composition of Human Immunodeficiency Virus Type 1 in Cerebrospinal Fluid and Blood without Treatment and during Failing Antiretroviral TherapyJournal of Virology, 2005